Search - tctmd.com

Displaying 21 - 39 of 39

Sort: Relevancy | Date

News Daily News

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Todd Neale

February 26, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

Presentation THT 2025

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Presenter: Devleena Das

February 13, 2025

Presentation THT 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT Abstracts 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Resurgence of Interest in the Role of Inflammation in HF

Presenter: Douglas Mann

February 11, 2025

Presentation THT 2025

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Presenter: Carolyn Lam

February 11, 2025

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

News Daily News

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Yael L. Maxwell

January 17, 2025

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

Todd Neale

January 21, 2024

Advertisement

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Inflammation as a Target in Acute HF

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Inflammation and HFpEF: Rationale for HERMES

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Resurgence of Interest in the Role of Inflammation in HF

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content